The oral Janus kinase inhibitor baricitinib (Olumiant) preserved beta-cell function in people with new-onset type 1 diabetes over 48 weeks, new phase 2 data show. A randomized, placebo-controlled ...

GLP-1 therapies help control blood sugar. Beyond this, research shows that these medications can reduce the risk of major ...

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

Recent clinical trials have shown promising results of transplanting these cells into individuals with Type 1 diabetes: ...

For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...